Technology
Health
Pharmaceutical

ContraVir

$3.91
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.10 (-2.51%) As of 3:42 PM EDT today
-$0.10 (-2.51%) Today

Why Robinhood?

You can buy or sell ContraVir and other stocks, options, ETFs, and crypto commission-free!

About CTRV

ContraVir Pharmaceuticals, Inc. engages in the development and commercialization of pleiotropic drug therapy for the treatment of chronic liver disease. It focuses on the development of its product candidate CRV431, a cyclophilin inhibitor that targets biochemical pathways involved in the progression of liver disease. Read More The company was founded on May 15, 2013 and is headquartered in Edison, NJ.

Employees
14
Headquarters
Edison, New Jersey
Founded
2013
Market Cap
1.19M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
207.50K
High Today
$4.14
Low Today
$3.85
Open Price
$3.95
Volume
182.09K
52 Week High
$91.00
52 Week Low
$3.52

Collections

Technology
Health
Pharmaceutical
Therapy
2014 IPO
US
North America

CTRV News

BenzingaJun 21

ContraVir Rebounds From Record Low On Positive FDA Feedback

1,929
MarketWatchJun 21

ContraVir's stock rockets off record low after 'positive feedback' on pre-IND for NASH

1,162
BenzingaJun 20

ContraVir, Korn Ferry Make Big Moves After Hours

1,378

CTRV Earnings

-$0.63
-$0.43
-$0.23
-$0.03
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
-$0.37 per share
Actual
Expected Aug 14, After Hours

More CTRV News

MarketWatchJun 19

ContraVir’s stock suffers record plunge after seesaw week of upbeat drug studies, mistaken filings and withdrawals of withdrawals

243
Seeking AlphaJun 18

Gyrating ContraVir Pharma on track for second biggest-ever one-day selloff

1,792
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.